World's Best Scientists 2026 revealed!
Laurence Klotz

Laurence Klotz

D-Index & Metrics

Medicine

D-Index
99
Citations
43240
World Ranking
8486
National Ranking
331

Overview

Laurence Klotz is affiliated with the University of Toronto in Canada and has contributed extensively to research in medicine, particularly focusing on prostate cancer and related fields. Their work spans several subfields including pulmonary and respiratory medicine, oncology, radiology, nuclear medicine and imaging, surgery, and endocrinology, diabetes, and metabolism.

The primary topics of Klotz's research include prostate cancer treatment and research, prostate cancer diagnosis and treatment, hormonal and reproductive studies, COVID-19 and healthcare impacts, bladder and urothelial cancer treatments, urologic and reproductive health conditions, and global cancer incidence and screening.

Klotz has co-authored publications with several frequent collaborators, including:

  • Joseph L. Chin
  • Neil Fleshner
  • Antonio Finelli
  • Luke T. Lavallée
  • Christian P. Pavlovich

Their research has been published predominantly in the following venues:

  • The Journal of Urology
  • Canadian Urological Association Journal
  • Journal of Clinical Oncology
  • European Urology
  • European Urology Oncology

Among the recent papers authored or co-authored by Klotz are:

  • Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer, 2021, JAMA Oncology
  • Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis, 2020, Canadian Urological Association Journal
  • Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer, 2020, The Journal of Urology

Other notable papers in which Klotz is involved or linked topics include:

  • Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study, 2020, The Journal of Urology
  • Intermediate-risk Prostate Cancer: Stratification and Management, 2020, European Urology Oncology

Best Publications

  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

    Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco

  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley

  • Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer

    Laurence Klotz;Liying Zhang;Adam Lam;Robert Nam

  • Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

    Laurence Klotz;Laurence Klotz;Danny Vesprini;Danny Vesprini;Perakaa Sethukavalan;Perakaa Sethukavalan;Vibhuti Jethava;Vibhuti Jethava

  • A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

    Hendrik Van Poppel;Luigi Da Pozzo;Walter Albrecht;Vsevolod Matveev

  • Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

    Martin G. Sanda;Jeffrey A. Cadeddu;Erin Kirkby;Ronald C. Chen

  • The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

    Laurence Klotz;Laurent Boccon-Gibod;Neal D. Shore;Cal Andreou

  • Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

    Robert K. Nam;Robert K. Nam;Refik Saskin;Yuna Lee;Ying Liu

  • Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

    Marc A. Dall’Era;Peter C. Albertsen;Christopher Bangma;Peter R. Carroll

  • Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.

    Caroline M. Moore;Caroline M. Moore;Nicola L. Robertson;Nasr Arsanious;Thomas Middleton

  • Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

    J. M Crook;C. J O'Callaghan;G Duncan;D. P Dearnaley

  • Feasibility Study: Watchful Waiting For Localized Low To Intermediate Grade Prostate Carcinoma With Selective Delayed Intervention Based On Prostate Specific Antigen, Histological And/Or Clinical Progression

    Richard Choo;Laurence Klotz;Cyril Danjoux;Gerard C. Morton

  • Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.

    Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton

  • Active Surveillance for Prostate Cancer: For Whom?

    Laurence Klotz

  • Loss of Cyclin-dependent Kinase Inhibitor p27Kip1 Is a Novel Prognostic Factor in Localized Human Prostate Adenocarcinoma

    Tsihlias J;Kapusta Lr;DeBoer G;Morava-Protzner I

  • Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group.

    M E Gleave;M Elhilali;Y Fradet;I Davis

  • Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist

    Peter C. Albertsen;Laurence Klotz;Bertrand Tombal;James Grady

  • Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review

    Ivo G. Schoots;Neophytos Petrides;Francesco Giganti;Leonard P. Bokhorst

  • RANDOMIZED COMPARATIVE STUDY OF 3 VERSUS 8-MONTH NEOADJUVANT HORMONAL THERAPY BEFORE RADICAL PROSTATECTOMY: BIOCHEMICAL AND PATHOLOGICAL EFFECTS

    Martin E. Gleave;S. Larry Goldenberg;Joseph L. Chin;John Warner

  • Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy

    Juanita M. Crook;Christopher J. O’Callaghan;Graeme Duncan;David P. Dearnaley

Frequent Co-Authors

Neil Fleshner
Neil Fleshner Princess Margaret Cancer Centre
Antonio Finelli
Antonio Finelli University Health Network
Steven A. Narod
Steven A. Narod University of Toronto
John Trachtenberg
John Trachtenberg University of Toronto
Arnauld Villers
Arnauld Villers University of Lille
Peter R. Carroll
Peter R. Carroll University of California, San Francisco
Martin E. Gleave
Martin E. Gleave University of British Columbia
Fred Saad
Fred Saad University of Montreal
Mark Emberton
Mark Emberton University College London
Nathan Lawrentschuk
Nathan Lawrentschuk University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in the broader healthcare field, there are several flexible alternatives to traditional medical study routes in the USA. Many pursue nursing, which offers a range of entry points whether or not you have previous healthcare experience. For those with a non-nursing background, non nursing bachelor's to msn online programs allow a direct pathway into advanced practice nursing.

If you are looking for less competitive entry to healthcare careers, consider applying to the easiest rn program where admission requirements can be more accessible. Additionally, candidates looking to become registered nurses may benefit from accelerated tracks, such as lpn to rn programs without teas test, reducing the barriers posed by entrance exams.

Not all healthcare roles require direct patient care. For example, administrative positions like medical billers and coders are in high demand. For added convenience, students can enroll at medical billing and coding online schools that accept financial aid, making this career path more affordable and flexible.

Best Scientists Citing Laurence Klotz

Trending Scientists

Recently Published Articles